Literature DB >> 14706091

Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.

S Chaniotaki1, P Giakouppi, L S Tzouvelekis, D Panagiotakos, M Kozanitou, G Petrikkos, A Avlami, A C Vatopoulos.   

Abstract

Susceptibility data for 10 049 Escherichia coli isolates derived from community-acquired urinary tract infections in Greece during the period January 2000 to June 2002 indicated 8.1% resistance to nalidixic acid and 36% resistance to ciprofloxacin. In a sample of 170 E. coli isolates, mutations in gyrA (25 isolates) and parC (15 isolates) were consistent with the levels of resistance to quinolones. Previous exposure to quinolones and underlying chronic disease were independent risk factors for infection by quinolone-resistant E. coli strains.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14706091     DOI： 10.1111/j.1469-0691.2004.00807.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  15 in total

1.  Emergence of the plasmid-mediated quinolone resistance gene qnrS1 in Escherichia coli isolates in Greece.

Authors:  Olga Vasilaki; Eleni Ntokou; Alexandros Ikonomidis; Danae Sofianou; Filanthi Frantzidou; Styliani Alexiou-Daniel; Antonios N Maniatis; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

Review 2.  Clinical importance and epidemiology of quinolone resistance.

Authors:  Eu Suk Kim; David C Hooper
Journal:  Infect Chemother       Date:  2014-12-29

Review 3.  Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy.

Authors:  Patricia Brown; Moran Ki; Betsy Foxman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec.

Authors:  Jacques Pépin; Mireille Plamondon; Caroline Lacroix; Isabelle Alarie
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Antimicrobial Selection in the Treatment of Pyelonephritis.

Authors:  Patricia D Brown
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

6.  Community acquired quinolone-resistant Escherichia coli pyelonephritis complicated with multiple renal abscesses: a case report.

Authors:  M Katsiari; C Nikolaou; Z Roussou; C Triantopoulou; D Apessou; Ed Platsouka; A Maguina
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

7.  Treatment duration of febrile urinary tract infections.

Authors:  Willize E van der Starre; Jaap T van Dissel; Cees van Nieuwkoop
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

8.  Fluoroquinolone-resistant Escherichia coli, Indonesia.

Authors:  Kuntaman Kuntaman; Endang Sri Lestari; Juliëtte A Severin; Irma M Kershof; Ni Made Mertaniasih; Marijam Purwanta; Usman Hadi; James R Johnson; Alex van Belkum; Henri A Verbrugh
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

9.  Trends of mortality due to septicemia in Greece: an 8-year analysis.

Authors:  Matthew E Falagas; Ioanna P Korbila; Anastasios Kapaskelis; Kyriaki Manousou; Lili Leontiou; Giannoula S Tansarli
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.

Authors:  Angeliki Mavroidi; Vivi Miriagou; Apostolos Liakopoulos; Εva Tzelepi; Angelos Stefos; George N Dalekos; Efthymia Petinaki
Journal:  BMC Infect Dis       Date:  2012-12-23       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.